JOHNSTON EUGENE M
SEC insider (Form 3/4/5 filer). CIK 0001254538. Chief Financial Officer at OFA Group (OFAL) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 28, 2026. Located in DALLAS, TX.
Companies JOHNSTON EUGENE M has filed insider reports for
- OFA Group (OFAL): Officer, Chief Financial Officer
- MANGOCEUTICALS, INC. (MGRX): Officer, CFO
JOHNSTON EUGENE M
CIK: 0001254538
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 28, 2026MGRX
MANGOCEUTICALS, INC.
AwardDirect100K shares- - Dec 15, 2025MGRX
MANGOCEUTICALS, INC.
SaleDirect3.3K shares at avg. $1.17$4K - Dec 9, 2025MGRX
MANGOCEUTICALS, INC.
SaleDirect5K shares at avg. $1.20$6K - Dec 5, 2025MGRX
MANGOCEUTICALS, INC.
SaleDirect10K shares at avg. $1.13$11K - Sep 9, 2025MGRX
MANGOCEUTICALS, INC.
AwardDirect100K shares- - Nov 11, 2024MGRX
MANGOCEUTICALS, INC.
AwardDirect25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 28, 2026 |  MGRX MANGOCEUTICALS, INC. | Award | 100,000 | - | $0 | Direct |
| Dec 15, 2025 | MGRX MANGOCEUTICALS, INC. | Sale | 3,333 | $1.17 | $3,884 | Direct |
| Dec 9, 2025 | MGRX MANGOCEUTICALS, INC. | Sale | 5,000 | $1.20 | $5,975 | Direct |
| Dec 5, 2025 | MGRX MANGOCEUTICALS, INC. | Sale | 10,000 | $1.13 | $11,280 | Direct |
| Sep 9, 2025 | MGRX MANGOCEUTICALS, INC. | Award | 100,000 | - | - | Direct |
| Nov 11, 2024 | MGRX MANGOCEUTICALS, INC. | Award | 25,000 | - | $0 | Direct |
1-6 of 6 transactions